The extracellular matrix protein Reelin is an essential regulator of neuronal migration and lamination in the developing and mature brain. Lack of Reelin causes severe disturbances in cerebral layering, such as the reeler phenotype and granule cell dispersion in temporal lobe epilepsy. Reelin is synthesized and secreted by Cajal-Retzius cells and GABAergic interneurons, and its function depends on proteolytic cleavage after secretion. The mechanisms regulating these processes are largely unknown. Here, we used rat hippocampal slice cultures to investigate the effect of neuronal activation and hyperexcitation on Reelin synthesis, secretion, and proteolytic processing. We show that enhanced neuronal activity does not modulate Reelin synthesis or secretion. Moreover, we found that intracellular Reelin resides predominantly in the endoplasmic reticulum before it is constitutively secreted via the early secretory pathway. Epileptiform activity, however, impairs the proteolytic processing of Reelin and leads to accumulation of Reelin in the extracellular matrix. We found that both conditions, epileptiform activity and impaired proteolytic cleavage of Reelin, cause granule cell dispersion via inhibition of metalloproteinases. Taken together, our results strongly suggest that secretion of Reelin is activityindependent and that proteolytic processing of Reelin is required for the maintenance of granule cell lamination in the dentate gyrus.-Tinnes, S., Schäfer, M. K. E., Flubacher, A., Münzner, G., Frotscher, M., Haas, C. A. Epileptiform activity interferes with proteolytic processing of Reelin required for dentate granule cell positioning. FASEB J. 25, 000 -000 (2011). www.fasebj.org
Granule cell dispersion (GCD) is a migration defect of dentate granule cells frequently associated with temporal lobe epilepsy (TLE; refs. 1, 2). The extracellular matrix protein Reelin has been shown to be involved critically in the development of GCD, since the Reelin-deficient reeler mouse (3, 4) shows a granule cell migration defect reminiscent of GCD (5-7). Moreover, both in hippocampi obtained from TLE patients and in experimental TLE models a local Reelin deficiency was found (2, 8) . In fact, a causal link between GCD formation and Reelin dysfunction has been established by the rescue of granule cell lamination through infusion of recombinant Reelin into the epileptic mouse hippocampus (9) . Furthermore, infusion of Reelinneutralizing antibodies has been shown to be sufficient to induce GCD in naive animals (8) , which suggests a role for Reelin in maintaining the adult dentate layering in addition to its functions in the developing brain (10, 11) .
In the hippocampus, Reelin is synthesized and secreted into the extracellular matrix (ECM) by Cajal-Retzius cells and interneurons (2, (12) (13) (14) . After secretion, the 400-kDa full-length Reelin is cleaved proteolytically into smaller isoforms, an important prerequisite for activation of target cells expressing the lipoprotein receptors, very-low-density lipoprotein receptor and apolipoprotein E receptor 2 (15) (16) (17) (18) (19) (20) .
Up to now, the role of Reelin in maintenance of granule cell lamination has been studied only with regard to changes in expression. It was not considered whether neuronal excitation affects the efficiency of Reelin secretion and proteolytic cleavage in the hippocampus. To address these questions, we took advantage of organotypic hippocampal slice cultures (OHCs) from young postnatal rats. OHCs have been proven to preserve organotypic characteristics, such as a regionspecific organization and cell-type specific features (21) ; allow the distinction between tissue-bound and secreted molecules by separate analysis of tissue extracts and supernatants; and serve as an in vitro model of epilepsy by application of glutamate receptor agonists (22) . Using OHC as a secretion and epilepsy model, we present evidence that secretion of Reelin is independent of neuronal excitation, but its proteolytic processing is severely affected under epileptic conditions.
MATERIALS AND METHODS

Organotypic slice cultures
OHCs were prepared from postnatal day 1-4 (P1-P4) rat pups as described (23) . In brief, after dissection, hippocampi were sliced (400 m) and incubated as static cultures in 5% CO 2 at 37°C in nutrition medium [46% minimal essential medium (MEM), 25% basal medium Eagle, 25% heat-inactivated horse serum supplemented with 0.65% glucose, and 2 mM glutamine, pH 7.2] for 7 days in vitro (DIV). The following treatments were performed: KCl (5 or 10 mM; Sigma-Aldrich, Munich, Germany); kainate (KA; 5, 10, 15, or 30 M; Tocris, Bristol, UK); tetrodotoxin (TTX; 1 M, Sigma-Aldrich); 6-cyano-7-nitroquinoxaline 2, 3-dione (CNQX; 10 or 20 M; Ascent Scientific, Weston-super-Mare, UK). CNQX was added to the cultures 30 min prior to KA. Brefeldin A (BFA; 9, 18, or 36 M; Sigma-Aldrich); matrix metalloproteinase (MMP) inhibitor GM 6001 (80 M; Calbiochem, Gibbstown, NJ, USA) and plasminogen activator inhibitor-1 (PAI-1; 1.15 g/ml; Chemicon, Temecula, CA, USA). Controls were incubated with nutrition medium only.
Western blot analysis
Western blot analysis was performed as described earlier (9) . In brief, 8 OHCs/treatment were pooled after incubation with the respective compounds and homogenized in loading buffer (Invitrogen, Karlsruhe, Germany). Equal amounts of protein (25 g) or supernatants (9 l) from OHCs or from transfected NSC-34 cells (see below) were size-fractionated by SDS-polyacrylamide gel electrophoresis (4 -8% Tris acetate gels) and blotted onto polyvinylidene difluoride membrane (Roche, Mannheim, Germany). Immunological detection was achieved using the following antibodies: mouse monoclonal anti-Reelin (G-10; 1:1000; Chemicon), goat polyclonal antineurofilament light chain (NF-L; 1:500), rabbit polyclonal anti-c-Fos (1:1000), and goat polyclonal anti-Actin (1:500; all from Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by incubation with the respective alkaline phosphataseconjugated secondary antibodies (1:10000; Tropix, Bedford, MA, USA). For normalization, blots were stripped and reprobed with either anti-Actin or anti-NF-L antibodies. Detection was accomplished by enhanced chemiluminescence using CDP Star as a substrate (Tropix). For documentation, images were captured using the Chemismart System (Peqlab Biotechnologies, Erlangen, Germany) equipped with a CCD camera.
Densitometric evaluation of Western blot signals was performed by optical density (OD) measurement using the Bio-1D software (Peqlab). Individual OD values for the 3 Reelin isoforms (400, 320, and 180 kDa) detected by the G10 antibody (24) were normalized with respect to the loading control. Mean Ϯ se values were calculated for each group (see Results for experimental details) and were expressed as percentage of control. Statistical significance was determined by 1-way analysis of variance (ANOVA) followed by DunnettЈs multiple comparison test. Values were considered as significant with P Ͻ 0.05.
Immunohistochemistry
After the respective treatment, OHCs were fixed in 4% buffered paraformaldehyde and resliced (20 m), followed by mounting of sections on gelatin-coated slides. Immunolabeling was performed in a humid chamber according to standard procedures. Incubation with anti-Reelin (1:1000; G-10) or anti-c-Fos (1:000) was performed overnight followed by exposure to a Cy3-conjugated secondary antibody (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and counterstaining with DAPI.
For double immunolabeling, sections were incubated with anti-KDEL (1:250; Santa Cruz Biotechnology) followed by exposure to Cy3-labeled Fab fragments (1:200; Jackson), and subsequent immunolabeling for Reelin was performed as described above, except that a Cy2-labeled secondary antibody was used.
Cresyl violet staining
To monitor granule cell layer (GCL) width, resliced OHCs were immersed in 0.1% cresyl violet solution, dehydrated in increasing concentrations of ethanol, cleared in xylene, and coverslipped.
Measurement of GCL width
Average GCL width was determined in cresyl violet-stained sections of control and KA-or protease inhibitor (PI; GMϩPAI-1)-treated OHCs. Six consecutive measurements were taken at 50-m intervals, covering a region of 300 m within the GCL, using the Axiovision software (Carl Zeiss, Jena, Germany). The mean of 6 measurements in Ն3 sections was calculated for each animal. Mean values of all animals/ groups were pooled, and statistical significance of differences between means was determined by 1-way ANOVA followed by Dunnett's multiple comparison test. Values of P Ͻ 0.05 were considered significant.
Cell counting
Reelin-immunolabeled cells were counted in control and KA-treated OHCs (Ն3 sections/animal; nϭ3/group) using Stereoinvestigator software (MicroBrightField, Williston, VT, USA). Two regions of interest (ROIs; along the hippocampal fissure and in the hilus) were defined; cell counting was performed with a ϫ40 objective. Cell numbers were standardized to the area of each ROI, and the mean Ϯ se was calculated for each group.
In situ zymography
MMP-2 and MMP-9 (gelatinase) activities were measured using dye-quenched (DQ) gelatin (Molecular Probes; Darmstadt, Germany). To this end, control and KA-treated OHCs were coated with DQ gelatin (100 g/ml in nutrition medium) as described by Wilczynski et al. (25) followed by fixation and counterstaining with DAPI. Gelatin-cleaved fluorescence was detected at 530 nm and quantified by OD measurement offline in 2 ROIs: in the molecular layer (ML) and the GCL of the dentate gyrus. Absolute OD values for each group were averaged, and statistical significance of differences between means was determined by 1-way ANOVA followed by Dunnett's multiple comparison test.
RNA extraction, reverse transcription, and quantitative real-time RT-PCR
Total RNA was isolated from 8 pooled OHCs/treatment using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription was performed in 20-l reactions containing ϳ1 g total RNA, 5 M random decamer primers, 500 M deoxyNTPs, 20 U RNase inhibitor, and 100 U of M-MLV reverse transcriptase (all from Ambion, Huntingdon, UK) for 60 min at 42°C.
Relative mRNA levels were determined by real-time quantitative RT-PCR on a MyiQ Real Time PCR Detection System (Bio-Rad Laboratories, München, Germany) in the presence of SYBR Green (ABgene, Hamburg, Germany), as described in detail previously (8) . The following rat-specific primer pairs (70 nM) were used: c-fos, forward 5Ј-TCTGTGACCTCCCTGGACTTG-3Ј, reverse 5Ј-GGGCTCAGGGTCATTGAGAA-3Ј; reelin, forward 5Ј-AGCAGGGTTCTGTGGCAATC-3Ј, reverse 5Ј-CGGGAG-GAGAGAGCATTGTG-3Ј; S12, forward 5Ј-GGGAATGGG-TAGGCCTCTGT-3Ј, reverse 5Ј-ACATCCTTGGCCTGAG-ATTCTTT-3Ј. Cycling conditions were as follows: 15 min at 95°C followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. Melting curves of the amplified products were used to control for specificity of the amplification reaction. From the amplification curves obtained, a threshold cycle (C t ) number was calculated, corresponding to the cycle number at which a user-defined fluorescence signal was reached. Differences in C t values were used to calculate relative amounts of the PCR products. All quantifications were normalized to the coamplified ribosomal S12 protein RNA, a housekeeping gene in the rodent brain.
Cell culture, transfection, and immunocytochemistry
Neuroblastoma spinal cord (NSC-34) cells (26) were cultured in MEM supplemented with 8% fetal calf serum on glass coverslips coated with poly-d-lysine (Sigma-Aldrich). Expression plasmids encoding for endoplasmic reticulum-green fluorescent protein (GFP-ER; BD Biosciences Clontech, Heidelberg, Germany), yellow fluorescent protein-trans-Golgi network protein 2 (YFP-TGN38), or GFP-ADP-ribosylation factor-1 (GFP-ARF1), respectively, were cotransfected with an expression plasmid encoding mouse Reelin (pCrl; ref. 27) using RotifectPlus (Roth, Karlsruhe, Germany). As negative control, cells were transfected with a mock plasmid. After 24 h, cells were fixed and Reelin (G-10; 1:2000) immunolabeling was performed as described above. Confocal images were captured with an inverted LSM 510 laser scanning microscope using a Plan-Apochromat ϫ63/1.4 oil DIC objective (Zeiss).
RESULTS
Analysis of Reelin synthesis and secretion following KCl or KA treatment in OHCs
As a prerequisite for all later experiments, we first investigated the pattern of Reelin-expressing cells and the isoform composition of Reelin in OHCs. By immunolabeling, we observed many Reelin-positive CajalRetzius cells at the hippocampal fissure, whereas large interneuron-like, immunolabeled cells were located in the hilus (Fig. 1A) . In addition, Western blot analysis revealed the 3 Reelin isoforms (400, 320, and 180 kDa), detectable with the G-10 antibody, in tissue extracts as well as in supernatants, except that secreted Reelin showed an increase in the relative abundance of the 320-kDa Reelin fragment (Fig. 1B) as described earlier (7).
Before studying potential effects of neuronal activation on Reelin synthesis and secretion, we verified in our OHC model the efficiency of depolarization by KCl or glutamate receptor activation by KA by examining the induction of the immediate early gene c-fos, a sensitive marker of neuronal activation (28) . At 3 h after treatment with KCl or KA, an increase of c-fos mRNA expression was elicited with 5 mM KCl, and a dose-dependent, strong accumulation of c-fos mRNA was seen after exposure to increasing (5, 10, 15, 30 M) concentrations of KA, whereas blockade of neuronal activity by TTX, a sodium channel blocker, did not induce c-fos mRNA expression (Supplemental Fig.  S1A ). Western blot analysis revealed a transient increase of c-Fos protein levels at 3 h after KCl treatment, followed by a subsequent decline at 24 h (Supplemental Fig. S1B , C). KA application elicited a stronger increase of c-Fos protein levels at 3 h, followed by a delayed drop at 24 h, when compared to the KCl response (Supplemental Fig. S1B , C). In addition, untreated control slices were devoid of any c-Fos immunostaining. KCl elicited a transient appearance of c-Fospositive neuronal nuclei within 1.5 h (Supplemental Fig. S1D , E), whereas the KA-stimulated c-Fos response was still maintained after 3h (Supplemental Fig. S1F, I ), indicating a stronger neuronal activation by KA.
Using the same conditions for Reelin analysis, we found that depolarization (5 mM KCl) or glutamate receptor activation (5 M KA) for 24 h did not affect reelin mRNA levels as revealed by real-time RT-PCR analysis (Fig. 1C) . Similarly, the same treatment did not alter Reelin protein levels in OHC tissue extracts or in supernatants when compared to untreated controls at three different time points (3, 24 , and 48 h; Fig. 1D-F) . These results show that neuronal activation does not influence synthesis or secretion of Reelin in OHC.
Effect of BFA treatment on Reelin release in OHC
To clarify whether Reelin is secreted in our OHC model in a Golgi apparatus-dependent manner, we disrupted the anterograde protein transport from the ER to the Golgi apparatus using BFA, which leads to ER accumulation of proteins transported by the early secretory pathway (29) .
OHCs were incubated for 12 h with 9, 18, or 36 M BFA. To exclude fast intracellular degradation of BFA, the culture medium containing fresh BFA was changed every 3 h, followed by immunostaining for Reelin and the ER-retention sequence KDEL (30) . In control OHCs, Reelin labeling was observed throughout the soma of Cajal-Retzius cells and overlapped to some degree with the ER-retention sequence KDEL (ref. 30 ; Fig. 2A-C) , indicating that Reelin passes the ER following synthesis. After BFA treatment, the Reelin staining was strongly altered from a diffuse cytoplasmic to a punctate, perinuclear localization. Colocalization of Reelin and KDEL was mainly observed in these punctate structures (Fig. 2D-F) , suggesting that Reelin accumulated in the ER following BFA-mediated destruction of the ER-Golgi complex.
In addition, Western blot analysis revealed that BFA treatment (at all 3 concentrations) caused the accumulation of 400-kDa full-length Reelin and a strong decrease of the 320-and 180-kDa Reelin isoforms in tissue preparations (Fig. 2G) . In supernatants of BFA-treated OHCs, Reelin levels were reduced (Fig. 2H) , indicating that BFA treatment inhibited the secretion of Reelin. Taken together, these data show that Reelin is secreted via the ER/Golgi-dependent early secretory pathway.
Cotransfection of Reelin and ER-or Golgi-specific expression constructs
To address the subcellular localization of Reelin in more detail, we overexpressed recombinant Reelin in NSC-34 cells. Immunoblot analysis of supernatants from mock-transfected NSC-34 cells did not reveal any secreted endogenous Reelin (Fig. 3A) , whereas the 3 Reelin isoforms were present in supernatants from Reelin-transfected NSC-34 cells (Fig. 3A) , indicating that recombinant Reelin was properly processed and secreted by these cells.
By cotransfection of Reelin and GFP-or YFP-tagged expression plasmids encoding marker proteins for the ER and the Golgi apparatus, we found that Reelin largely overlapped with the GFP-tagged ER retention sequence KDEL (Fig. 3B) . Conversely, much less colocalization was observed with the cis-Golgi marker GFP-ARF1 (Fig. 3C) or the trans-Golgi-marker YFP-TGN38 (Fig. 3D ). In summary, these experiments show that intracellular Reelin is predominantly localized in the ER compartment, in agreement with our findings obtained in OHCs.
Effects of epileptic conditions on Reelin-synthesizing cells and Reelin isoform composition
The results presented so far relate to synthesis and secretion of Reelin in rat hippocampus under physiological conditions. As previous studies from our laboratory have shown that epileptic conditions in vivo are associated with decreased Reelin expression and GCD formation (2, 8, 9, 31), we next studied potential effects of neuronal hyperexcitation on Reelin secretion. To this end, we induced epileptiform activity in OHC by high doses of KA (22) and investigated their effect on Reelin-synthesizing neurons, GCD formation, and Reelin secretion in vitro.
Immunolabeling for Reelin after treatment with increasing concentrations of KA for 24 h followed by 6 DIV revealed that in OHC Reelin-positive cells displayed a differential sensitivity to KA receptor activation. At the hippocampal fissure Cajal-Retzius were not affected by KA treatment, whereas in the hilus the number of Reelin-immunolabeled interneurons dropped significantly (13% of control) in response to KA (Fig. 4) .
Next, we analyzed in the same treatment regime the effect of KA on GCL layering by measurement of GCL width in Nissl-stained sections. Application of KA caused a concentration-dependent, significant widening of the GCL (up to Ϯ82 m) when compared to untreated controls (Ϯ48 m; Fig. 5A-D) , showing that GCD can be induced in OHCs.
Finally, we investigated the acute effect of KA on Reelin protein expression after 24 h of treatment. Quantitative Western blot analysis revealed that Reelin isoform composition was altered severely by increasing doses of KA: in tissue, the relative amounts of the high-MW 320-kDa Reelin isoform increased significantly in a dose-dependent manner (10 M, 89%; 15 M KA, 160%; 30 M KA, 230%), whereas the 180-kDa isoform remained unchanged (Fig. 6A, B) . In supernatants, the levels of the 180-kDa Reelin isoform decreased significantly (Fig. 6C,  D) . These effects were mediated specifically by KA receptors because combined application of KA and the competitive KA receptor antagonist CNQX inhibited the KA-mediated accumulation of high-MW Reelin isoforms (Supplemental Fig. S2) . On the mRNA level, we found by real-time RT-PCR that reelin mRNA expression was not altered at 3 and 24 h after treatment with increasing doses of KA (Fig. 6E, F) , showing that high KA doses did not stimulate de novo synthesis of Reelin within this time range.
In summary, we show that in our OHC model epileptic conditions cause a selective loss of Reelin-synthesizing neurons and the development of GCD as described in vivo. In addition, we found that epileptic activity leads to accumulation of high-MW Reelin in hippocampal tissue and to decreased levels of the smaller 180-kDa fragment in supernatants, pointing to a KA-mediated inhibition of proteolytic processing of Reelin.
Analysis of Reelin following inhibition of Reelin-processing proteases
To test this hypothesis, we treated OHCs with GM 6001, a potent, cell-permeable, broad-spectrum inhibitor of matrix metalloproteinases (MMPs) and investigated Reelin isoform composition by quantitative Western blot analysis. Application of GM 6001 for 24 h caused a significant, 2.3-fold accumulation of the 320-kDa Reelin isoform in tissue (Fig. 7A, B) accompanied by a 40% decrease of the secreted 180-kDa Reelin fragment in supernatants; the amounts of the high-MW Reelin isoforms were not altered (Fig. 7C, D) . These changes in Reelin isoform composition exactly mirror the ones found after KA treatment, indicating that indeed a failure of proteolytic Reelin cleavage underlies the KA-mediated accumulation of high-MW Reelin isoforms.
PI treatment in OHCs causes GCD
In order to test for the functional relevance of impaired Reelin processing, we directly studied the effect of PIs on GCL lamination. OHCs were incubated for 1 wk with the PIs GM 6001 and PAI-1, followed by measurement of GCL width. PAI-1 was included in this experiment, since plasminogen activators have been described as Reelin processing proteases (18) . Combined application of PIs resulted in a significant increase of GCL width from 47 m (untreated controls) to 70 m (Fig. 8A-C) . PI efficacy was confirmed by Western blot analysis, which showed the accumulation of high-MW Reelin isoforms in tissue and the decrease of the cleaved 180-kDa fragment in supernatants of PI-treated OHC (Fig. 8D) .
When the distribution of Reelin-synthetizing cells was investigated in PI-treated OHCs, we observed a shift in the localization of Reelin: in controls, immunolabeling for Reelin was mainly seen intracellularly (Fig. 8 E, G) , whereas in PI-treated tissue, Reelin-immunostaining appeared to concentrate extracellularly around CajalRetzius cells (Fig. 8F, H) , suggesting the accumulation of Reelin in the ECM.
Quantification of gelatinase activity in OHCs after KA treatment
The results presented so far point to a KA-mediated decrease of proteolytic activity, which in turn might lead to reduced cleavage of Reelin. To clarify this point, we used quantitative in situ zymography with gelatin as substrate, which is specific for monitoring MMP-2 and MMP-9 activity in tissue.
In control OHCs, we found a bright, diffuse fluorescence staining, derived from gelatin cleavage, which covered the whole slice (Fig. 9A, B) . In particular, the cell-poor, plexiform layers of the dentate gyrus and the cornus ammonis regions displayed strong fluorescence, which is compatible with extracellular MMP activity (32) . After KA treatment for 24 h, the diffuse fluorescence intensity was strongly reduced, while the number of fluorescence-labeled cells appeared to increase when compared to controls (Fig. 9C-F) . Densitometric evaluation in our ROIs (ML and GCL) revealed a significant decline of fluorescence intensity in these areas.
DISCUSSION
The main findings of this study are as follows: under physiological conditions, Reelin is secreted in rat hippocampus in a constitutive, activity-independent manner via the ER/Golgi pathway and resides mainly in the ER before secretion; epileptic conditions, however, cause a selective loss of hilar interneurons in OHCs, the development of GCD, and the accumulation of high-MW Reelin isoforms in tissue and a reduced secretion of the small (180-kDa) Reelin fragment; the latter can be mimicked by application of PIs, which alone is sufficient to disturb GCL layering and to cause accumulation of secreted Reelin in the ECM around surviving Cajal-Retzius cells.
Reelin secretion in rat hippocampus depends on the ER/Golgi complex and is not modulated by neuronal activity
The prerequisite for the function of Reelin is its secretion from Cajal-Retzius cells or interneurons and the subsequent binding of Reelin to target cells expressing Reelin receptors. Here, we mimicked in vivo conditions by using rat OHCs and investigated the mode of Reelin secretion. Neither KCl-induced depolarization nor KA-mediated glutamate receptor activation, confirmed by successful c-fos induction, altered either reelin mRNA synthesis or Reelin secretion, indicating a constitutive and activity-independent secretion mode. Moreover, we show that Reelin release depends on the ER/Golgi pathway, since destruction of the ER/Golgi trafficking by BFA largely reduced the Reelin content in OHC supernatants and resulted in a perinuclear accumulation of Reelin. Accordingly, coexpression of Reelin and compartment-specific markers in NSC-34 cells revealed that Reelin predominantly resides in the ER before secretion. These results confirm and extend previous in vitro studies on cell lines or cultured primary neurons showing that Reelin is secreted into the medium under basal conditions (7, 19, 27, 33) , that it is not influenced by neuronal activation (33) , and that it is released in a ER/Golgi dependent manner (15, 33) . Our data are also consistent with reports about the secretion-deficient reeler Orleans mutant in which intracellular Reelin accumulates in the ER (15, 34 -36) and with a recent study in knock-in mice expressing a mutant form of the binding immunoglobulin protein, an ER-resident molecular chaperone important for ER function. In these mutants, Cajal-Retzius cells fail to secrete Reelin and show cerebral and cerebellar malformations similar to the reeler phenotype (37) . Altogether, our results and published data substantiate the depen- dency of Reelin secretion on the ER for its proper function.
Consequences of epileptic activity on expression and proteolytic processing of Reelin
Previously, we have shown that in human and rodent hippocampus, epileptic conditions lead to a decrease of Reelin-synthesizing cells. As a consequence, Reelin levels drop in the epileptic hippocampus (2, 8, 38) , entailing GCD (for review see ref. 31) , which inspired the hypothesis that Reelin is required as positional cue for adult dentate granule cells (2, 8, 9) . So far, it was unresolved, however, why already a reduction of Reelin levels, and not a complete loss like in the reeler mouse, causes such a dramatic displacement of granule cells.
Here, we used OHCs as an in vitro system to resolve this controversy. We found that under epileptic conditions, induced by high doses of KA, GCD develops just like in TLE patients (2) and after intrahippocampal KA injection in mice (8, 9, 39) . However, in our OHC model, immunolabeling revealed that Reelin-positive Cajal-Retzius cells at the hippocampal fissure survive, whereas in the hilus, Reelin-synthesizing cells vanish, resulting in a Reelin loss confined to the hilar region. The observed difference in survival rate between interneurons and Cajal-Retzius cells is most likely due to differential expression of glutamate receptors, since only hilar interneurons, but not Cajal-Retzius cells, up-regulate c-Fos after KA treatment (unpublished results).
How can a bidirectional widening of the GCL be explained, when the positional information is lost only in the hilus? In fact, we found that under epileptic conditions, high-MW Reelin isoforms (400 and 320 kDa) accumulated in tissue, while secretion of the small 180-kDa fragment was reduced. This finding suggests that hyperexcitation inhibits the proteolytic cleavage of Reelin released by surviving Cajal-Retzius cells at the hippocampal fissure and that a functional inactivation by impaired proteolytic processing plays a role in GCD formation.
Application of PIs is sufficient to induce GCD
Proteolytic processing of Reelin has been shown to be important for its biological function; however, it is controversially discussed which cleavage product activates the Reelin signal transduction cascade on target cells. In some studies, the so-called central Reelin fragment, consisting of repeats 3-6, is crucial for receptor activation (19 -20) , others claim that a smaller fragment, repeats 5-6, is important (40) . Here, we used PIs to test the functional significance of Reelin processing in GCD development. When we inhibited MMPs by application of GM 6001, we could mimic the KA effect, namely the accumulation of the high-MW Reelin isoforms (400 and 320 kDa) in tissue and decreased secretion of the small 180-kDa fragment, indicating that KA indeed inhibits Reelin processing. In addition, PI application to OHCs was sufficient to induce GCD within 1 wk, and in these slices Reelin accumulated in the ECM around CajalRetzius cells. Combined application of recombinant Reelin and PI blocked GCD formation, indicating the specificity of this effect (unpublished results). Of note, Jossin et al. (20) proposed that Reelin is anchored to the ECM after secretion and that the central fragment is released only by proteolysis, since inhibition of MMP disturbed proper layer formation during development of the cerebral cortex.
How does epileptic activity affect Reelin processing?
It is tempting to speculate that in our model, MMPs are inactivated by epileptic activity, resulting in an impairment of Reelin processing. MMPs are secreted or membrane-bound zinc-dependent endopeptidases that regulate the metabolism of the pericellular environment, in particular the turnover of ECM proteins (41) . In fact, after KA treatment, we found a decrease of gelatinolytic (ϭMMP) activity in the ML and GCL by in situ zymography, indicating that KA indeed causes a reduction of MMP activity in the regions where surviving Cajal-Retzius cells are located. It is possible that tissue inhibitors of metalloproteases (TIMPs), known to control the activity of MMPs (42) , are involved in the down-regulation of MMP activity in our system. In fact, TIMP-1 expression has been shown to increase rapidly in the hippocampus following seizures (43) (44) . Moreover, in TIMP-1-deficient mice, no widening of the GCL was observed after systemic KA application (44) . Hence it is conceivable that in our model, epileptic activity induces TIMP-1, which, in turn, inactivates MMPs, resulting in an impairment of Reelin processing.
Altogether, we suggest the following scenario: KAinduced epileptic activity causes the death of Reelinproducing hilar interneurons and inhibits MMP activity in the vicinity of surviving, Reelin-secreting Cajal-Retzius cells. In turn, cleavage of extracellular Reelin is impaired; Reelin accumulates in the ECM and fails to activate a sufficient number of Reelin receptors on dentate granule cells. Hence we conclude that both the loss of Reelin in the hilus and functional inactivation of Reelin by impaired processing contribute to the displacement of adult dentate granule cells. 
